Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-01 1:0:43 pm | Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations | GlobeNewsWire |
| 2024-01-07 1:0:0 pm | Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference | GlobeNewswire |
| 2024-01-05 1:0:0 pm | Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies | GlobeNewswire |
| 2023-12-21 11:22:19 pm | Retail investors account for 43% of Molecular Partners AG's (VTX:MOLN) ownership, while hedge funds account for 33% | Simply Wall St. |
| 2023-12-13 10:0:0 pm | Molecular Partners to Present at 42nd Annual J.P. Morgan Healthcare Conference and Swiss Investor Conferences | GlobeNewswire |
| 2023-12-10 9:0:0 am | Molecular Partners Presents Positive Initial Data from First Four Dosing Cohorts of Ongoing Phase 1/2a Trial of MP0533 for Patients with Relapsed/Refractory AML and AML/MDS at ASH Annual Meeting | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information